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Introduction
The first clinical application of a catheter ab-
lation technique was to create complete atrioven-
tricular (AV) block by the transcatheter delivery
of a direct-current shock to the AV junction in
patients with supraventricular tachycardia re-
fractory to pharmacologic therapy.^'^ This was
followed by attempts at catheter ablation of ven-
tricular tachycardia (VT) foci, accessory path-
ways, and atrial tachycardia foci. The purpose of
this article is to provide a perspective on the cur-
rent role of these catheter ablation techniques in
the management of patients with tachyarrhyth-
mias.
General Comments
Requirements for Physicians Performing
Catheter Ahlation
Physicians who perform catheter ablation
procedures should be competent in all areas of
clinical electrophysiology. This requires a mini-
mum of one year of training devoted to clinical
electrophysiology. The physician must be able to
determine accurately tachycardia hiechanisms,
to identify and localize accessory pathways, arid
to map the exit sites of ventricular tachycardia. In
addition to technical competency in these areas,
the physician should be experienced with the use
of pharmacologic therapy, devices such as the au-
tomatic implantable cardioverter/defibrillator,
and the surgical approaches to the therapy of
tachycardias. The interests of the patient are best
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served by physicians who are experienced not
only with catheter ablation techniques, but also
with the other available forms of nonpharmaco-
logic therapy. Only physicians who are familiar
with the pros and cons of all forms of nonphar-
macologic therapy are able to select the best form
of therapy for a given patient.
Resources Necessary for Performing
Catheter Ahlation
Certain resources must be available for per-
forming detailed electrophysiologic studies in the
initial evaluation of potential catheter ablation
candidates.
A cardiothoracic surgeon and an operating
room equipped for cardiopulmonary bypass
should be immediately available in the event of
cardiac tamponade. Although the risk of perfora-
tion of a myocardial structure is small with the
catheter ablation techniques currently in use, it is
nevertheless possible that a catheter-related
problem may result in a misdirected shock and
myocardial or coronary sinus perforation. Surgi-
cal back-up, therefore, must be available.
In addition, hospitals in which catheter abla-
tion procedures are performed should have the
capability for continuous electrocardiographic
tnonitoring in the post-ablation period. Patients
must be carefully observed for the occurrence of
new arrhythmias related to the intracardiac
shocks.
Catheter Ablation of the
AV Junction
Efficacy and Risk
The Percutaneous Mapping and Ablation
Registry has accumulated data on the efficacy and
98 January 1988 PAGE, Vol. 11
MORADY
ery of shocks to the wall of the right atrium or in
the right atrial appendage.^^^ Experience with
this technique is preliminary and any conclusions
regarding its role in the management of patients
who have atrial tachycardias would be prema-
ture.
Expectations for the Future
Development of a catheter technique which
reliably modifies AV conduction without creating
high degree AV block would result in resolution
of symptomatic tachycardias without the need for
a permanent pacemaker. Modification of the AV
junction has been difficult to achieve with di-
rect-current shocks, but it is possible that better
techniques will be developed with the use of laser
or radiofrequency. Eventually, catheter "modifi-
cation" (as opposed to "ablation") may become a
reasonable alternative to pharmacologic therapy,
instead of a last resort, in patients who have
symptomatic supraventricular tachycardias.
At this point, it seems unlikely that catheter
ablation will ever assume a major role in the
treatment of patients with VT who often have
diffuse myocardial disease and multiple potential
VT foci. Furthermore, in many cases there may
not be an actual VT "focus," but instead a large
area of macroreentry. It therefore may be unreal-
istic to expect that any technique which produces
small and discrete lesions will be effective in a
large proportion of patients who have recur-
rent VT,
Preliminary experience suggests that cath-
eter ablation of posteroseptal and right free-wall
accessory pathways may have an acceptable
risk/benefit ratio. More accurate mapping tech-
niques will undoubtedly be important for im-
proving results of catheter ablation of right-sided
accessory pathways. It remains to be determined
whether a safe and effective catheter technique
for ablating left free-wall accessory pathways can
be developed.
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